Guidance
Update information
June 2023: We have reviewed the evidence on emollient bath additives and updated our recommendations on emollients. The new recommendation is marked [2023].
Recommendations marked [2007, amended 2023] were updated without an evidence review, to remove references to emollient bath additives and make them consistent with the new recommendation.
Recommendations marked [2007] last had an evidence review in 2007.
Recommendations marked [2004] are from NICE's technology appraisal guidance on frequency of application of topical corticosteroids for atopic eczema and NICE's technology appraisal guidance on tacrolimus and pimecrolimus for atopic eczema.
March 2021: We withdrew some recommendations on managing bacterial infections because they have been replaced by the NICE guideline on secondary bacterial infection of eczema and other common skin conditions.
October 2020: A note about the Medicines and Healthcare products Regulatory Agency (MHRA) warnings on the fire hazard of emollient residue was added to the section on emollients. Footnotes were moved into the main text and tables updated to better meet accessibility requirements.
ISBN: 978-1-4731-5233-5